| Filed On | Filing |
|---|---|
| 30 Oct 2026 |
Form 4: Rooney Robert Gerald, Director
Received 23,474.1784 shares as a grant or award ($100K) |
| 30 Sep 2026 |
Form 4: Haden Patrick C, Director
Disposed of 63,000 shares (Open Market Purchase) ($267K) |
| 08 Sep 2026 | SCHEDULE 13G/A |
| 03 Sep 2026 | N-CSRS |
| 27 Aug 2026 | N-PX |
| 27 Aug 2026 | NPORT-P |
| 26 Aug 2026 | 40-17G |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 06 Aug 2026 | Proxy statement: annual meeting on September 15, 2026 |
| 05 Aug 2026 | N-CSR/A |
| 30 Jul 2026 | SCHEDULE 13G/A |
| 06 Jul 2026 | SCHEDULE 13G/A |
| 27 May 2026 | NPORT-P |
| 15 May 2026 | SCHEDULE 13G |
| 12 May 2026 | SCHEDULE 13G |
| 05 May 2026 | SCHEDULE 13G/A |
| 06 Apr 2026 | SCHEDULE 13G/A |
| 30 Mar 2026 |
Form 4: Rogers Victoria B, Director
Received 5,400 shares by exercise ($24.1K) |
| 30 Mar 2026 |
Form 4: Rooney Robert Gerald, Director
Received 8,833 shares by exercise ($39.5K) · Exercised 20,499 Subscription Rights for Shares of Common Stock (right to buy |
| 30 Mar 2026 |
Form 4: McMillan Peter, Director
Received 193,761 shares by exercise ($866K) |
Loading...